288 related articles for article (PubMed ID: 27170106)
1. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
Wen Q; Kim CS; Hamilton PW; Zhang SD
BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
[TBL] [Abstract][Full Text] [Related]
2. An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.
Thillaiyampalam G; Liberante F; Murray L; Cardwell C; Mills K; Zhang SD
BMC Bioinformatics; 2017 Dec; 18(1):581. PubMed ID: 29268695
[TBL] [Abstract][Full Text] [Related]
3. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies.
Wen Q; O'Reilly P; Dunne PD; Lawler M; Van Schaeybroeck S; Salto-Tellez M; Hamilton P; Zhang SD
BMC Syst Biol; 2015; 9 Suppl 5(Suppl 5):S4. PubMed ID: 26356760
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.
McArt DG; Zhang SD
PLoS One; 2011 Jan; 6(1):e16382. PubMed ID: 21305029
[TBL] [Abstract][Full Text] [Related]
5. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.
Fortney K; Griesman J; Kotlyar M; Pastrello C; Angeli M; Sound-Tsao M; Jurisica I
PLoS Comput Biol; 2015 Mar; 11(3):e1004068. PubMed ID: 25786242
[TBL] [Abstract][Full Text] [Related]
6. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.
Lu Y; Lemon W; Liu PY; Yi Y; Morrison C; Yang P; Sun Z; Szoke J; Gerald WL; Watson M; Govindan R; You M
PLoS Med; 2006 Dec; 3(12):e467. PubMed ID: 17194181
[TBL] [Abstract][Full Text] [Related]
7. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
8. Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.
Sun Y; Zhang W; Chen Y; Ma Q; Wei J; Liu Q
Oncotarget; 2016 Feb; 7(8):9404-19. PubMed ID: 26824188
[TBL] [Abstract][Full Text] [Related]
9. Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer.
Raghavan R; Hyter S; Pathak HB; Godwin AK; Konecny G; Wang C; Goode EL; Fridley BL
BMC Genomics; 2016 Oct; 17(1):811. PubMed ID: 27756228
[TBL] [Abstract][Full Text] [Related]
10. A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
Wong KM; Ding K; Li S; Bradbury P; Tsao MS; Der SD; Shepherd FA; Chung C; Ng R; Seymour L; Leighl NB
Clin Lung Cancer; 2017 Jan; 18(1):e41-e47. PubMed ID: 27502323
[TBL] [Abstract][Full Text] [Related]
11. Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.
Pasini A; Delmonte A; Tesei A; Calistri D; Giordano E
Drugs; 2015 Oct; 75(15):1757-71. PubMed ID: 26347133
[TBL] [Abstract][Full Text] [Related]
12. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
Balko JM; Potti A; Saunders C; Stromberg A; Haura EB; Black EP
BMC Genomics; 2006 Nov; 7():289. PubMed ID: 17096850
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of potential targets and drugs for non-small cell lung cancer.
Huang CH; Wu MY; Chang PM; Huang CY; Ng KL
IET Syst Biol; 2014 Apr; 8(2):56-66. PubMed ID: 25014226
[TBL] [Abstract][Full Text] [Related]
14. A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer.
Xu W; Jia G; Davie JR; Murphy L; Kratzke R; Banerji S
J Thorac Oncol; 2016 Dec; 11(12):2150-2160. PubMed ID: 27498386
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of lung development-cancer expression associations reveals the roles of signatures with inverse expression patterns.
Zhang C; Li C; Xu Y; Feng L; Shang D; Yang X; Han J; Sun Z; Li Y; Li X
Mol Biosyst; 2015 May; 11(5):1271-84. PubMed ID: 25720795
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
Damaskos C; Tomos I; Garmpis N; Karakatsani A; Dimitroulis D; Garmpi A; Spartalis E; Kampolis CF; Tsagkari E; Loukeri AA; Margonis GA; Spartalis M; Andreatos N; Schizas D; Kokkineli S; Antoniou EA; Nonni A; Tsourouflis G; Markatos K; Kontzoglou K; Kostakis A; Tomos P
Anticancer Res; 2018 Jan; 38(1):37-43. PubMed ID: 29277754
[TBL] [Abstract][Full Text] [Related]
17. Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data.
McArt DG; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Hamilton PW; Zhang SD
PLoS One; 2013; 8(6):e66902. PubMed ID: 23840550
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.
Gridelli C; De Marinis F; Di Maio M; Cortinovis D; Cappuzzo F; Mok T
Lung Cancer; 2011 Mar; 71(3):249-57. PubMed ID: 21216486
[TBL] [Abstract][Full Text] [Related]
19. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.
Huang SF; Liu HP; Li LH; Ku YC; Fu YN; Tsai HY; Chen YT; Lin YF; Chang WC; Kuo HP; Wu YC; Chen YR; Tsai SF
Clin Cancer Res; 2004 Dec; 10(24):8195-203. PubMed ID: 15623594
[TBL] [Abstract][Full Text] [Related]
20. QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
O'Reilly PG; Wen Q; Bankhead P; Dunne PD; McArt DG; McPherson S; Hamilton PW; Mills KI; Zhang SD
BMC Bioinformatics; 2016 May; 17(1):198. PubMed ID: 27143038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
